2-COMPARTMENT OPEN-SYSTEM KINETIC-MODEL - REVIEW OF ITS CLINICAL IMPLICATIONS AND APPLICATIONS

被引：39

作者：

LOUGHNAN, PM

SITAR, DS

OGILVIE, RI

NEIMS, AH

机构：

[1] MCGILL UNIV, DEPT PHARMACOL & THERAPEUTICS, ROCHE DEV PHARMACOL UNIT, MONTREAL, QUEBEC, CANADA

[2] MONTREAL GEN HOSP, DIV CLIN PHARMACOL, MONTREAL, QUEBEC, CANADA

来源：

关键词：

D O I：

10.1016/S0022-3476(76)81135-3

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：869 / 873

页数：5

共 13 条

[1] VOLUME TERMS IN PHARMACOKINETICS
BENET, LZ
RONFELD, RA
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (05) : 639 - &
[2] BOYES RN, 1971, CLIN PHARMACOL THER, V12, P105
[3] GIBALDI M, 1971, CLIN PHARMACOL THER, V12, P734
[4] GOLDSTEIN A, 1974, PRINCIPLES DRUG ACTI, P311
[5] EFFECTS OF CHANGE IN ELIMINATION ON VARIOUS PARAMETERS OF 2-COMPARTMENT OPEN MODEL
JUSKO, WJ
GIBALDI, M
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (08) : 1270 - &
[6] PROCAINAMIDE DOSAGE SCHEDULES, PLASMA CONCENTRATIONS, AND CLINICAL EFFECTS
KOCHWESER, J
KLEIN, SW
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 215 (09) : 1454 - +
[7] PHARMACOKINETICS OF DRUG ACTION
LEVY, G
GIBALDI, M
[J]. ANNUAL REVIEW OF PHARMACOLOGY, 1972, 12 : 85 - +
[8] MITENKO PA, 1973, CLIN PHARMACOL THER, V14, P509
[9] MITENKO PA, 1972, CLIN PHARMACOL THER, V13, P329
[10] REIGELMAN S, 1968, J PHARM SCI, V57, P128